SWOG clinical trial number
SWOG-9241
Evaluation of Topotecan in Colorectal Cancer, Phase II
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Evaluation of Topotecan in Colorectal Cancer, Phase II
Activated
07/15/1993
Closed
11/15/1994
Research committees
Gastrointestinal Cancer
Publication Information Expand/Collapse
1997
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Ocnology Group trial (SWOG-9241).
Other Clinical Trials
SWOG Clinical Trial Number
CTSU/A022101
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
SWOG Clinical Trial Number
S2107
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
Accrual
74%
Open
Phase
SWOG Clinical Trial Number
S2104
A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Research Committee(s)
Gastrointestinal Cancer
Activated
10/14/2021
Accrual
28%
Open
Phase